The Europe next generation sequencing market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017. The market is estimated to grow with a CAGR of 21.4% from 2018-2025.

Europe Next Generation Sequencing Market Overview

The European next-generation sequencing (NGS) market is driven by significant technological advancements and developments in genomics. However, the market is held back by a lack of skilled professionals and the high risks associated with genetic data privacy. Advancements in molecular biology have improved sequencing procedures, leading many companies to introduce innovative NGS technologies. This progress has led to the emergence of the New Bioeconomy, which replaces petrochemical-based manufacturing. For example, Roche launched new AVENIO Tumor Tissue Analysis Kits in 2018. Other dominant systems include Illumina's HiSeq 2000 and AB's SOLiD, which are widely used for oncology research and other applications.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/TIPRE00005459

Europe Next Generation Sequencing Market Strategies

Strategic insights for the European NGS market provide a data-driven analysis of the industry landscape, including trends and key players. These insights offer actionable recommendations that help businesses differentiate themselves by identifying untapped segments or developing unique value propositions. By leveraging data analytics, these insights help industry players anticipate future market shifts. A future-oriented perspective is essential for positioning companies for long-term success in this dynamic region. Ultimately, effective strategic insights empower stakeholders to make informed decisions that drive profitability and help them achieve their business objectives. This knowledge is crucial for thriving in the competitive market.

Europe Next Generation Sequencing Market Insights

The geographic scope in the European NGS market refers to the specific areas where a business operates and competes. Understanding local distinctions, such as diverse consumer preferences, varying economic conditions, and different regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet unique local demands. A clear market focus allows for more effective resource allocation and targeted marketing campaigns. This strategic clarity also enables better positioning against local competitors, ultimately driving growth in those targeted areas and ensuring a more sustainable and successful business model.

EUROPE NEXT GENERATION SEQUENCING - MARKET SEGMENTATION

By Product

  • Consumables
  • Services
  • Platforms




By Technology

  • Genome Sequencing
  • Exome Sequencing
  • Resequencing & Targeted Sequencing
  • Other




By Application

  • Diagnostics
  • Drug Discovery
  • Precision Medicine
  • Others




By End User

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Others




By Geography

  • Europe
  • UK
  • Germany
  • France




Company Profiles

  • Illumina, Inc.
  • Thermo Fisher
  • Qiagen N.V.,
  • Beijing Genomics Institute
  • PerkinElmer, Inc.
  • F.Hoffman-La Roche Ltd.
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd.
  • Macrogen Inc.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications